Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 23355L106 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Glenview Capital Management, LLC
13G/A
Amendment 1
|
0% |
8/14/2026
Event 6/30/2026
|
|
| Glenview Capital Management, LLC | 0% | ||
| Robbins Larry | 0% | ||
|
American Century Investment Management, Inc.
13G/A
Amendment 1
|
6.4% |
8/14/2026
Event 6/30/2026
|
|
| American Century ETF Trust | 6.2% | ||
| American Century Investment Management, Inc. | 6.4% | ||
| American Century Companies, Inc. | 6.4% | ||
| Stowers Institute for Medical Research | 6.4% | ||
|
Millennium Management LLC
13G/A
Amendment 1
|
4.1% |
8/12/2026
Event 6/30/2026
|
|
| Millennium Management LLC | 4.1% | ||
| Millennium Group Management LLC | 4.1% | ||
| Israel A. Englander | 4.1% | ||
| BlackRock, Inc. 13G/A Amendment 9 | 16.2% |
7/28/2026
Event 6/30/2026
|
|
| Dimensional Fund Advisors LP 13G/A Amendment 1 |
5.0%
Checked 5% or less
|
7/14/2026
Event 6/30/2026
|
|
|
Millennium Management LLC
13G
|
5.7% |
6/24/2026
Event 6/16/2026
|
|
| Millennium Management LLC | 5.7% | ||
| Millennium Group Management LLC | 5.7% | ||
| Israel A. Englander | 5.7% | ||
|
American Century Investment Management, Inc.
13G
|
5.4% |
5/1/2026
Event 3/31/2026
|
|
| American Century ETF Trust | 5.1% | ||
| American Century Investment Management, Inc. | 5.4% | ||
| American Century Companies, Inc. | 5.4% | ||
| Stowers Institute for Medical Research | 5.4% | ||
| Vanguard Portfolio Management LLC 13G | 7.7% |
4/29/2026
Event 3/31/2026
|
|
| Vanguard Capital Management LLC 13G | 5.2% |
4/29/2026
Event 3/31/2026
|
|
|
Glenview Capital Management, LLC
13G
|
5.2% |
3/27/2026
Event 3/20/2026
|
|
| Glenview Capital Management, LLC | 5.2% | ||
| Robbins Larry | 5.2% | ||
| Vanguard Group Inc 13G/A Amendment 9 | 0% |
3/26/2026
Event 3/13/2026
|
|
| Invesco Ltd. 13G/A Amendment 1 |
5.0%
Checked 5% or less
|
8/7/2025
Event 6/30/2025
|
|
|
Glenview Capital Management, LLC
13G/A
Amendment 3
|
3.8% |
5/15/2025
Event 3/31/2025
|
|
| Glenview Capital Management, LLC | 3.8% | ||
| Larry Robbins | 3.8% | ||
|
Pacer Advisors, Inc.
13G/A
Amendment 1
|
1.3% |
5/2/2025
Event 3/31/2025
|
|
| Pacer US Cash Cows 100 ETF | 0% | ||
| Pacer US Small Cap Cash Cows ETF | 1.3% | ||
| Pacer Data and Digital Revolution ETF | 0% | ||
| Pacer Advisors, Inc. | 1.3% | ||
| Joe M. Thomson | 1.3% | ||
|
Pacer Advisors, Inc.
13G
|
10.0% |
5/2/2025
Event 12/31/2024
|
|
| Pacer US Cash Cows 100 ETF | 5.7% | ||
| Pacer US Small Cap Cash Cows ETF | 4.3% | ||
| Pacer Data and Digital Revolution ETF | 0% | ||
| Pacer Advisors, Inc. | 10.0% | ||
| Joe M. Thomson | 10.0% | ||
| BlackRock, Inc. 13G/A Amendment 8 | 12.7% |
4/30/2025
Event 3/31/2025
|
|
| Vanguard Group Inc 13G/A Amendment 8 | 13.1% |
1/30/2025
Event 12/31/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 22 | 94.5 k | $861 k |
| 2026 Q2 | 452 | 181 M | $1.78 B |
| 2026 Q1 | 456 | 167 M | $2.10 B |
| 2025 Q4 | 429 | 160 M | $2.34 B |
| 2025 Q3 | 440 | 161 M | $2.19 B |
| 2025 Q2 | 454 | 161 M | $2.46 B |
| 2025 Q1 | 480 | 160 M | $2.73 B |
| 2024 Q4 | 450 | 168 M | $3.35 B |
| 2024 Q3 | 450 | 170 M | $3.52 B |
| 2024 Q2 | 449 | 179 M | $3.43 B |
| 2024 Q1 | 454 | 185 M | $3.93 B |
| 2023 Q4 | 462 | 184 M | $4.22 B |
| 2023 Q3 | 457 | 179 M | $3.73 B |
| 2023 Q2 | 511 | 183 M | $4.88 B |
| 2023 Q1 | 523 | 196 M | $5.01 B |
| 2022 Q4 | 569 | 212 M | $5.59 B |
| 2022 Q3 | 543 | 209 M | $5.12 B |
| 2022 Q2 | 536 | 200 M | $6.07 B |
| 2022 Q1 | 566 | 209 M | $6.82 B |
| 2021 Q4 | 573 | 217 M | $6.99 B |
| 2021 Q3 | 569 | 219 M | $7.35 B |
| 2021 Q2 | 609 | 218 M | $8.49 B |
| 2021 Q1 | 569 | 214 M | $6.70 B |
| 2020 Q4 | 602 | 218 M | $5.60 B |
| 2020 Q3 | 568 | 216 M | $3.85 B |
| 2020 Q2 | 578 | 218 M | $3.60 B |
| 2020 Q1 | 601 | 224 M | $2.93 B |
| 2019 Q4 | 680 | 237 M | $8.89 B |
| 2019 Q3 | 664 | 227 M | $6.69 B |
| 2019 Q2 | 767 | 238 M | $13.5 B |
| 2019 Q1 | 795 | 232 M | $14.9 B |
| 2018 Q4 | 776 | 239 M | $12.7 B |
| 2018 Q3 | 900 | 255 M | $23.9 B |
| 2018 Q2 | 853 | 247 M | $19.9 B |
| 2018 Q1 | 894 | 243 M | $24.4 B |
| 2017 Q4 | 858 | 244 M | $23.2 B |
| 2017 Q3 | 745 | 245 M | $21.1 B |
| 2017 Q2 | 726 | 246 M | $18.9 B |
| 2017 Q1 | 68 | 7.43 M | $443 M |
| 2016 Q4 | 1 | 317 | $19.0 k |
| 2016 Q3 | 1 | 21.7 k | $1.87 M |
| 2016 Q1 | 1 | 8.42 k | $541 k |